For animal nutritionists, feed manufacturers, and livestock producers, the presence of non-starch polysaccharides (NSPs) in cereal-based feeds represents a persistent challenge to feed efficiency and animal performance. β-glucans, the primary NSPs in barley, wheat, and oats, create viscous environments in the digestive tract of monogastric animals (poultry, swine) and aquaculture species, reducing nutrient digestibility, slowing feed passage, and contributing to wet litter and health issues. Traditional feed formulations address this challenge through diet formulation and ingredient selection, but these approaches limit the use of cost-effective cereal grains. Feed β-glucanase enzymes offer a targeted solution: exogenous enzymes that degrade β-glucans directly in the digestive tract, breaking down these anti-nutritional factors and releasing bound nutrients. As livestock producers face pressure to reduce feed costs, improve sustainability, and maintain animal health, the adoption of feed enzyme technologies has expanded significantly. Addressing these nutritional imperatives, Global Leading Market Research Publisher QYResearch announces the release of its latest report “Feed β-Glucanase - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. This comprehensive analysis provides stakeholders—from animal nutritionists and feed manufacturers to livestock producers and enzyme technology investors—with critical intelligence on an enzyme category that is fundamental to optimizing feed utilization and animal performance.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6098209/feed----glucanase

Market Valuation and Growth Trajectory

The global market for Feed β-Glucanase was estimated to be worth US$ 45.83 million in 2025 and is projected to reach US$ 75.21 million, growing at a CAGR of 7.4% from 2026 to 2032. In 2024, global production reached 7,120 tons, with an average global market price of US$ 4,010 per ton. This steady growth trajectory reflects the increasing demand for feed efficiency solutions, the expansion of monogastric livestock production, and the growing recognition that enzyme additives deliver measurable improvements in feed conversion and animal performance.

Product Fundamentals and Technological Significance

Feed β-glucanase refers to exogenous β-glucan-degrading enzymes produced by fungal or bacterial fermentation. It is a functional enzyme preparation specifically used in the feed industry. Its primary function is to degrade β-glucans, the non-starch polysaccharide components in the cell walls of cereals (such as barley, wheat, and oats), reducing their anti-nutritional effects in the animal digestive tract, thereby improving feed utilization. It is used in monogastric animals such as poultry and pigs, as well as in aquaculture.

β-glucans are linear polysaccharides composed of glucose units linked by β-1,3 and β-1,4 glycosidic bonds. In the digestive tract of monogastric animals, which lack endogenous β-glucanase enzymes, these polymers create viscous solutions that: reduce nutrient diffusion to the intestinal wall; slow gastric emptying and feed passage; trap bile acids, reducing fat digestion; and create an environment favorable for pathogenic bacteria. The anti-nutritional effects are most pronounced in barley-based diets, where β-glucan content can reach 4-7%, but also occur in wheat and oat formulations. Feed β-glucanase enzymes hydrolyze these polymers into smaller oligosaccharides, reducing viscosity and liberating nutrients trapped within the cell wall matrix. Key benefits include: improved feed conversion, reducing feed required per unit of weight gain; increased nutrient digestibility, particularly for energy, protein, and fat; reduced wet litter in poultry operations; enhanced gut health, by reducing the substrate for pathogenic bacteria; and formulation flexibility, enabling greater use of cost-effective barley and wheat in feed formulations. Enzymes are produced through submerged fermentation using selected microbial strains (Trichoderma reesei, Aspergillus niger) with optimized activity at gastrointestinal pH and temperature.

Market Segmentation and Application Dynamics

Segment by Type:

• Acidic — Represents enzymes with optimal activity in the acidic environment of the stomach (pH 3-5). Acidic β-glucanases are suited for monogastric applications where enzyme activity begins in the gastric phase.

• Neutral — Represents enzymes with optimal activity in the neutral to slightly alkaline environment of the small intestine (pH 6-7). Neutral β-glucanases provide continued activity through the intestinal phase.

Segment by Application:

• Swine — Represents a significant segment, with β-glucanase used in pig diets to improve energy digestibility and reduce feed costs. Swine applications benefit from improved growth performance and reduced fecal output.

• Poultry — Represents the largest segment, with β-glucanase widely used in broiler and layer diets to improve feed conversion and reduce wet litter. Poultry applications have strong economic returns due to the sensitivity of birds to diet viscosity.

• Aquaculture — Represents a growing segment, with β-glucanase used in fish and shrimp feeds to improve digestibility of plant-based ingredients and reduce reliance on fishmeal.

• Others — Includes ruminant and specialty animal applications.

Competitive Landscape and Geographic Concentration

The feed β-glucanase market features a competitive landscape dominated by global enzyme manufacturers with extensive fermentation capabilities and animal nutrition expertise. Key players include Novozymes, AB Enzymes, DSM-Firmenich, Aum Enzymes, BASF, Kemin Industries, Creative Biogene, Guangdong Vtr Bio-Tech, Wuhan Sunhy Biology, Fuda Biotech, Sunson Industry Group, Beijing Strowin Biotechnology (BSB), Shandong Sukahan Bio-Technology, and Qingdao Vland Biotech.

A distinctive characteristic of this market is the leadership of European enzyme manufacturers with global distribution, alongside strong Chinese producers serving domestic and export markets. Novozymes and DSM-Firmenich represent the global leaders, with extensive enzyme portfolios, fermentation capacity, and animal nutrition expertise. AB Enzymes, BASF, and Kemin Industries are established competitors with strong presence in feed additives. Chinese manufacturers—including Wuhan Sunhy, Fuda Biotech, and Shandong Sukahan—have captured significant domestic market share and are expanding export presence with cost-competitive offerings.

Exclusive Industry Analysis: The Divergence Between Poultry and Swine β-Glucanase Applications

An exclusive observation from our analysis reveals a fundamental divergence in β-glucanase requirements between poultry and swine applications—a divergence that reflects different digestive physiology, feed formulations, and economic drivers.

In poultry applications, β-glucanase is used to reduce diet viscosity and wet litter, with significant economic benefits from improved feed conversion. A case study from a large broiler integrator illustrates this segment. The integrator includes β-glucanase in starter and grower feeds, reducing feed conversion ratio by 3-5 points. The enzyme also reduces litter moisture, improving bird health and reducing processing costs.

In swine applications, β-glucanase focuses on improving energy digestibility and reducing feed costs. A case study from a swine operation illustrates this segment. The operation uses β-glucanase in grow-finish diets to improve digestibility of barley-based formulations, reducing feed cost per pig. The enzyme also reduces fecal output, lowering manure management costs.

Technical Challenges and Innovation Frontiers

Despite market maturity, feed β-glucanase faces persistent technical challenges. Thermostability is critical for feed manufacturing, as enzymes must survive the heat of feed pelleting (70-85°C). Enzyme manufacturers develop thermostable formulations and use feed processing strategies to protect enzyme activity.

Activity across digestive pH range requires enzyme blends with activity in both acidic and neutral conditions. Multi-enzyme formulations combining β-glucanase with xylanase, phytase, and other enzymes provide broader benefits.

A significant technological catalyst emerged in early 2026 with the commercial validation of β-glucanase enzymes with enhanced thermostability and protease resistance, enabling application in a wider range of feed formulations and processing conditions.

Policy and Regulatory Environment

Recent policy developments have influenced market trajectories. Feed additive regulations in major markets establish requirements for enzyme safety and efficacy. Antibiotic reduction initiatives in livestock production drive adoption of feed additives that support gut health, including β-glucanase. Sustainability programs in animal agriculture encourage practices that improve feed efficiency and reduce environmental impact.

Regional Market Dynamics and Growth Opportunities

Asia-Pacific represents the largest and fastest-growing market for feed β-glucanase, driven by China's massive livestock and poultry production, growing aquaculture sector, and increasing adoption of enzyme technologies. North America and Europe represent significant markets with mature enzyme adoption and focus on feed efficiency and antibiotic reduction.

For animal nutritionists, feed manufacturers, livestock producers, and enzyme technology investors, the feed β-glucanase market offers a compelling value proposition: steady growth driven by feed efficiency demands, enabling technology for optimal nutrient utilization, and innovation opportunities in thermostable formulations and multi-enzyme blends.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp